2728 Stock Overview
Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of proprietary Chinese medicines, chemical preparations, raw materials, and products in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Teyi Pharmaceutical Group Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.77 |
| 52 Week High | CN¥24.48 |
| 52 Week Low | CN¥11.55 |
| Beta | 1.58 |
| 1 Month Change | -8.54% |
| 3 Month Change | -14.23% |
| 1 Year Change | -6.52% |
| 3 Year Change | 84.13% |
| 5 Year Change | 22.57% |
| Change since IPO | 105.14% |
Recent News & Updates
Shareholder Returns
| 2728 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -7.4% | -2.0% | -2.7% |
| 1Y | -6.5% | -17.1% | -18.2% |
Return vs Industry: 002728 exceeded the CN Pharmaceuticals industry which returned -17.1% over the past year.
Return vs Market: 002728 exceeded the CN Market which returned -18.2% over the past year.
Price Volatility
| 2728 volatility | |
|---|---|
| 2728 Average Weekly Movement | 7.8% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 11.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002728 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002728's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 1,243 | n/a | www.tczy.com.cn |
Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of proprietary Chinese medicines, chemical preparations, raw materials, and products in the People’s Republic of China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular and cerebrovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd.
Teyi Pharmaceutical Group Co.,Ltd Fundamentals Summary
| 2728 fundamental statistics | |
|---|---|
| Market cap | CN¥5.39b |
| Earnings (TTM) | CN¥253.18m |
| Revenue (TTM) | CN¥1.07b |
21.3x
P/E Ratio5.0x
P/S RatioIs 2728 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2728 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.07b |
| Cost of Revenue | CN¥467.98m |
| Gross Profit | CN¥599.23m |
| Other Expenses | CN¥346.05m |
| Earnings | CN¥253.18m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 20, 2024
| Earnings per share (EPS) | 0.69 |
| Gross Margin | 56.15% |
| Net Profit Margin | 23.72% |
| Debt/Equity Ratio | 15.2% |
How did 2728 perform over the long term?
See historical performance and comparison